Overview
WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop and manufacture biologics from concept to commercialization for the benefit of patients worldwide.
Company Events
A Novel Conjugation Technology that Generates ADCs with a Narrowly Distributed DAR
Dec 13, 2023
Virtual Webinar